Acadia Healthcare Company shares were up 4% Friday after the company reported late Thursday Q4 adjusted earnings per share (EPS) that beat analyst estimates. Non-GAAP EPS for the quarter was $0.59, the same as a year earlier. That compared with an average analyst estimate of $0.55 in a Capital IQ poll.
Revenue for the quarter rose to $702.9 million from $495.3 million a year earlier. That missed the average analyst forecast of $708.66. The company said it expects revenue for 2017 in a range of $2.85 billion to $2.9 billion, up from $2.8 billion in 2016, and about in line with the $2.9 billion mean estimate.
It forecasts adjusted EPS for 2017 in a range $2.40 to $2.50, compared with $2.45 in 2016. Analysts see $2.53 in a Capital IQ poll. In Q1 2017 it expects adjusted EPS of between $0.45 and $0.47. That is below analyst estimates of $0.56 according to Capital IQ.